HealthLeaders-InterStudy, a leading provider of managed care industry intelligence, finds that CIGNA HealthCare of Tennessee stands to capture more than 120,000 more self-insured members in the state. According to Tennessee Health Plan Analysis from HealthLeaders-InterStudy, CIGNA submitted the lowest and winning bids to administer health insurance for state and local government and education employees.

"CIGNA is back in the business of capturing market share," said Jane DuBose, HealthLeaders-InterStudy analyst. "This is the first time in a long time that Aetna isn't a participant, and it also cuts Blue Cross out of its current contract for middle and west Tennessee."

CIGNA's proposal included lower administrative fees, and met criteria ranging from network access to claims payment adequacy. The lower fees make state government a big winner in the deal.

  Other health plan news in Tennessee:   -- With the exception of Blue Cross Blue Shield of Tennessee, insurers do      not plan to offer low-cost products aimed at the 191,000 being cut from      TennCare's rolls this summer and fall   -- Tennessee HMO profit margins rose in the first quarter of 2004   -- Cariten Healthcare is joining the ranks of health plans offering      consumer-driven options with its FlexAppeal product    About HealthLeaders-InterStudy 

HealthLeaders-InterStudy, a company of Decision Resources, Inc. (http://www.decisionresources.com/), is the authoritative source for managed care data, analysis, and news. For more information, please visit http://www.healthleaders.com/.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

   For more information, contact:     Alex Jablokow    Decision Resources    781-296-2562    ajablokow@dresources.com 

SOURCE: Decision Resources, Inc.

CONTACT: Alex Jablokow of Decision Resources, +1-781-296-2562,
ajablokow@dresources.com

Novartis's Vildagliptin and Merck's Sitagliptin will Achieve Blockbuster Status in the Market to Treat Type 2 Diabetes

View Now